Assessment of spatial technology companies requires a focus on core technical and service parameters. Researchers evaluating their options for a spatial omics service must consider three critical aspects: the resolution and dimensionality of the data, the physical scale of tissue analysis supported, and the project turnaround time. Companies like STOmics enter this landscape with specific technological approaches that define their offerings. The choice between different spatial technology companies often hinges on how these elements align with a project’s specific aims.
Resolution and Data Dimensionality
A primary differentiator among spatial technology companies is the resolution of their platforms. Some services offer cellular-level data, while others provide subcellular detail. STOmics utilizes its Stereo-seq technology to achieve high-resolution mapping. This capability allows a spatial omics service to simultaneously capture transcriptomic and proteomic information from a single tissue section, providing a multi-dimensional view that is critical for complex research.
Tissue Scale and Analysis Area
The physical scale of tissue that can be analyzed in a single run is another practical consideration. Projects involving large tissue sections or requiring a broad field of view need a platform designed for such a scale. The complete tissue section solution from STOmics addresses this need. Their integrated approach, including specialized chips and imaging hardware, is built to manage large-area analysis, which is a key feature for many users of a spatial omics service.
Project Timeline and Integrated Workflow
The timeline from sample to result, or turnaround time, is an operational factor for laboratories. This encompasses hands-on preparation, instrument run time, and data analysis. A streamlined workflow can reduce complexity. STOmics provides an end-to-end toolkit, which includes reagent kits, the Go Optical imager, and bioinformatics software like SAW. This integrated model offered by spatial technology companies aims to create a more predictable and efficient pathway for researchers.
In summary, comparing providers in the spatial omics field involves weighing specific technical capabilities against project requirements. Resolution dictates the depth of insight, scale determines the breadth of tissue analysis, and integrated workflows influence practical timelines. For researchers seeking a coordinated solution, STOmics represents one approach where these elements are combined within a single platform’s ecosystem.
